Cliff Asness's UTMD Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 10,271 shares of Utah Medical Products, Inc. (UTMD) worth $636,709, representing 0.00% of the portfolio. First purchased in 2018-Q2, this long-term strategic position has been held for 22 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in UTMD, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2018, adding 27,286 shares. Largest reduction occurred in Q4 2020, reducing 9,234 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Utah Medical Products (UTMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Utah Medical Products (UTMD) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -378 | Reduce 3.55% | 10,271 | $61.99 |
| Q4 2025 | -4,757 | Reduce 30.88% | 10,649 | $55.96 |
| Q3 2025 | +6,786 | Add 78.72% | 15,406 | $62.97 |
| Q2 2025 | +8,620 | New Buy | 8,620 | $56.92 |
| Q4 2024 | -8,874 | Sold Out | 0 | $0.00 |
| Q3 2024 | +1,723 | Add 24.09% | 8,874 | $66.91 |
| Q2 2024 | +7,151 | New Buy | 7,151 | $66.81 |
| Q3 2022 | -5,346 | Sold Out | 0 | $0.00 |
| Q2 2022 | +2,218 | Add 70.91% | 5,346 | $85.86 |
| Q1 2022 | +3,128 | New Buy | 3,128 | $89.83 |
| Q1 2021 | -4,840 | Sold Out | 0 | $0.00 |
| Q4 2020 | -9,234 | Reduce 65.61% | 4,840 | $84.30 |
| Q3 2020 | -58 | Reduce 0.41% | 14,074 | $79.86 |
| Q2 2020 | -225 | Reduce 1.57% | 14,132 | $88.59 |
| Q1 2020 | +281 | Add 2.00% | 14,357 | $94.03 |
| Q4 2019 | -3,742 | Reduce 21.00% | 14,076 | $107.91 |
| Q3 2019 | -220 | Reduce 1.22% | 17,818 | $95.86 |
| Q2 2019 | -1,416 | Reduce 7.28% | 18,038 | $95.69 |
| Q1 2019 | -2,617 | Reduce 11.86% | 19,454 | $88.26 |
| Q4 2018 | -7,279 | Reduce 24.80% | 22,071 | $83.10 |
| Q3 2018 | +27,286 | Add 1322.00% | 29,350 | $94.21 |
| Q2 2018 | +2,064 | New Buy | 2,064 | $109.98 |
Cliff Asness's Utah Medical Products Investment FAQs
Cliff Asness first purchased Utah Medical Products, Inc. (UTMD) in Q2 2018, acquiring 2,064 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Utah Medical Products, Inc. (UTMD) for 22 quarters since Q2 2018.
Cliff Asness's largest addition to Utah Medical Products, Inc. (UTMD) was in Q3 2018, adding 29,350 shares worth $2.76 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 10,271 shares of Utah Medical Products, Inc. (UTMD), valued at approximately $636,709.
As of the Q1 2026 filing, Utah Medical Products, Inc. (UTMD) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Utah Medical Products, Inc. (UTMD) was 29,350 shares, as reported at the end of Q3 2018.